Why the study?
Does quantitative contrast-enhanced CMR measuring LGE improve the assessment of SCD event risk in patients with hypertrophic cardiomyopathy?
Does quantitative contrast-enhanced CMR measuring LGE improve the assessment of SCD event risk in patients with hypertrophic cardiomyopathy?
Extensive LGE on CMR helps stratify sudden cardiac death risk in HCM patients, especially those otherwise considered low risk.
No takes yet. Share an insight, caveat, or question.
May aid SCD risk stratification in low-risk HCM; hypothesis-generating and should not yet change ICD practice.
Chan et al. (2014) studied this question.
Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context: